Dynavax CFO Kelly MacDonald: Making An Impact In The Biotech Industry [Forbes]
Dynavax Technologies Corporation (DVAX)
Last dynavax technologies corporation earnings: 3/11 04:10 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.dynavax.com
Company Research
Source: Forbes
Kelly MacDonald is the CFO of Dynavax , a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines to help protect the world against infectious diseases. Based in the San Francisco Bay Area, Dynavax has one commercial product: HELPLISAV-B®, an adult Hepatitis B vaccine which is approved for use in the U.S. and throughout Europe. It is made using the company's proprietary CpG 1018® adjuvant, which was also supplied for use in multiple COVID-19 vaccines. I recently had a great conversation with Kelly about her upbringing, her path to work in the pharmaceutical industry and take on the CFO role, the importance and impact of mentorship, and the people who motivate her to put her best foot forward in everything she does. — Kelly MacDonald's upbringing in Burlington, Conn., sounds like a description of idyllic, small town American life. It was a town that, during her childhood, had fewer than 6,000 people living there and what she describes as one
Show less
Read more
Impact Snapshot
Event Time:
DVAX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DVAX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DVAX alerts
High impacting Dynavax Technologies Corporation news events
Weekly update
A roundup of the hottest topics
DVAX
News
- Dynavax Technologies Co. (NASDAQ: DVAX) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.MarketBeat
- Dynavax to Report First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024PR Newswire
- Dynavax Technologies Co. (NASDAQ: DVAX) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.MarketBeat
- Global Human Vaccines Market (2023-2028) [Yahoo! Finance]Yahoo! Finance
- Those who invested in Dynavax Technologies (NASDAQ:DVAX) five years ago are up 68% [Yahoo! Finance]Yahoo! Finance
DVAX
Earnings
- 2/22/24 - Beat
DVAX
Sec Filings
- 4/26/24 - Form DEFA14A
- 4/11/24 - Form ARS
- 4/11/24 - Form DEFA14A
- DVAX's page on the SEC website